Desmopressin Nasal Spray recall
FDA recall D-0510-2026 · initiated Apr 8, 2026
Apotex Corp. recalled Desmopressin Nasal Spray in Apr 2026 — an FDA Class II recall (D-0510-2026) because Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Labelling, packaging or a product mix-up
The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: N/A
Details
- Product
- Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
- Recalling company
- Apotex
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- U.S.A. Nationwide
- Initiated
- Apr 8, 2026
- FDA report date
- Apr 22, 2026
Frequently asked
- Was Desmopressin Nasal Spray recalled?
- Apotex Corp. recalled Desmopressin Nasal Spray in Apr 2026 — an FDA Class II recall (D-0510-2026) because Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Desmopressin Nasal Spray recalled?
- Per the FDA enforcement record, the reason for recall D-0510-2026 was: Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
- Is a recalled Desmopressin Nasal Spray dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Desmopressin Nasal Spray are affected?
- Distributed: U.S.A. Nationwide. The recall covers these lots — Lot #: VM4231, Exp 06/30/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0510-2026.